1. Home
  2. XNCR vs LFMD Comparison

XNCR vs LFMD Comparison

Compare XNCR & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNCR
  • LFMD
  • Stock Information
  • Founded
  • XNCR 1997
  • LFMD 1994
  • Country
  • XNCR United States
  • LFMD United States
  • Employees
  • XNCR N/A
  • LFMD N/A
  • Industry
  • XNCR Biotechnology: Pharmaceutical Preparations
  • LFMD Medical/Nursing Services
  • Sector
  • XNCR Health Care
  • LFMD Health Care
  • Exchange
  • XNCR Nasdaq
  • LFMD Nasdaq
  • Market Cap
  • XNCR 579.3M
  • LFMD 480.8M
  • IPO Year
  • XNCR 2013
  • LFMD N/A
  • Fundamental
  • Price
  • XNCR $9.65
  • LFMD $12.72
  • Analyst Decision
  • XNCR Buy
  • LFMD Strong Buy
  • Analyst Count
  • XNCR 8
  • LFMD 5
  • Target Price
  • XNCR $29.29
  • LFMD $11.00
  • AVG Volume (30 Days)
  • XNCR 968.8K
  • LFMD 1.9M
  • Earning Date
  • XNCR 08-04-2025
  • LFMD 05-06-2025
  • Dividend Yield
  • XNCR N/A
  • LFMD N/A
  • EPS Growth
  • XNCR N/A
  • LFMD N/A
  • EPS
  • XNCR N/A
  • LFMD N/A
  • Revenue
  • XNCR $127,228,000.00
  • LFMD $234,007,330.00
  • Revenue This Year
  • XNCR N/A
  • LFMD $29.80
  • Revenue Next Year
  • XNCR $29.35
  • LFMD $18.03
  • P/E Ratio
  • XNCR N/A
  • LFMD N/A
  • Revenue Growth
  • XNCR N/A
  • LFMD 43.07
  • 52 Week Low
  • XNCR $7.16
  • LFMD $3.99
  • 52 Week High
  • XNCR $27.24
  • LFMD $13.25
  • Technical
  • Relative Strength Index (RSI)
  • XNCR 59.62
  • LFMD 76.75
  • Support Level
  • XNCR $8.76
  • LFMD $11.69
  • Resistance Level
  • XNCR $9.60
  • LFMD $13.25
  • Average True Range (ATR)
  • XNCR 0.52
  • LFMD 0.84
  • MACD
  • XNCR 0.29
  • LFMD -0.00
  • Stochastic Oscillator
  • XNCR 90.87
  • LFMD 82.90

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

About LFMD LifeMD Inc.

LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.

Share on Social Networks: